Cadrenal Therapeutics, Inc. (CVKD) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US1276362076
Cadrenal Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -13.46 m USD |
| EBIT | -13.46 m USD |
| Net income | -13.24 m USD |
| Diluted EPS – continuing operations | -6.64 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions. The company is developing Tecarfarin, an oral vitamin K antagonist that is in Phase 3 clinical trial designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, and atrial fibrillation; CAD-1005, a first-in-class 12-LOX inhibitor for the treatment of heparin-induced thrombocytopenia, a deadly immune-mediated thrombotic disorder that has completed Phase 2 clinical trial; and Frunexian, a parenteral clinical-stage factor XIa inhibitor designed for use in acute hospital settings that has completed Phase 1 clinical trial. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
More stocks
- Perfect Moment Ltd. (PMNT)
- GD Culture Group Ltd (GDC)
- I-ON Digital Corp. (IONI)
- Scienture Holdings, Inc. (SCNX)
- AMARIN CORP PLC\UK (AMRN)
- Pulmatrix, Inc. (PULM)
- Aqua Metals, Inc. (AQMS)
- REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
- AleeanPeace Group Holdings Ltd (APGH)
- Luvu Brands, Inc. (LUVU)
- Versus Systems Inc. (VS)
- Limitless X Holdings Inc. (LIMX)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.